What it sells
Antibody-drug conjugate R&D
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-13 | Series A | CNY 300M+ | 夏尔巴投资 (lead) | news.google.com |
| 2026-10-13 | Series A | CNY 300M+ | 夏尔巴投资 (lead) | news.google.com |
| 2026-10-13 | Series A | CNY 300M+ | — | news.google.com |
| 2026-10-13 | Series A | CNY 300M+ | — | news.google.com |
| 2026-10-13 | Series A | CNY 300M+ | Sherpa Investment (lead) | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-17.